Radiopharmaceuticals

DBCAT001840Pharmacologic class

Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. A DrugBank category of 29 drugs. 23 of them are approved.

Drugs: Besilesomab
Bevacizumab zirconium Zr-89
Copper oxodotreotide Cu-64
Edotreotide
Edotreotide gallium Ga-68
Fludeoxyglucose (18F)
Fluoroazomycin arabinoside F-18
Flutemetamol
Flutemetamol (18F)
Gallium citrate
Gallium Ga-68 gozetotide
Iobenguane
Iofetamine I-123
Lutetium Lu 177 dotatate
Lutetium Lu-177 vipivotide tetraxetan
Lutetium Lu177 Edotreotide
Pentetreotide
Rose bengal I-131
Technetium Tc-99m disofenin
Technetium Tc-99m etidronate
Technetium Tc-99m exametazime
Technetium Tc-99m mebrofenin
Technetium Tc-99m medronate
Technetium Tc-99m pertechnetate
Technetium Tc-99m pyrophosphate
and 4 more with a free account

What you can answer from here — as of August 24, 2016

29DrugsEach linked to its full drug card

19Drug targetsEvery drug–target pair in the class, with bond type

297Marketed productsAcross the regions we cover, with dosage forms and routes

9Routes of administrationHow the drugs in this class are given

Which targets do Radiopharmaceuticals share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account